Connection

MANDEEP BAJAJ to Insulin Resistance

This is a "connection" page, showing publications MANDEEP BAJAJ has written about Insulin Resistance.
Connection Strength

2.551
  1. PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins. Cardiovasc Drugs Ther. 2014 Oct; 28(5):447-57.
    View in: PubMed
    Score: 0.333
  2. Nicotine and insulin resistance: when the smoke clears. Diabetes. 2012 Dec; 61(12):3078-80.
    View in: PubMed
    Score: 0.293
  3. NF-kappaB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: blockade by adiponectin. Endocrinology. 2011 Oct; 152(10):3622-7.
    View in: PubMed
    Score: 0.268
  4. Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients. Metab Syndr Relat Disord. 2010 Apr; 8(2):113-8.
    View in: PubMed
    Score: 0.244
  5. Paradoxical changes in muscle gene expression in insulin-resistant subjects after sustained reduction in plasma free fatty acid concentration. Diabetes. 2007 Mar; 56(3):743-52.
    View in: PubMed
    Score: 0.197
  6. Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004 Jun 03; 350(23):2419-21; author reply 2419-21.
    View in: PubMed
    Score: 0.163
  7. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord. 2004 Jun; 28(6):783-9.
    View in: PubMed
    Score: 0.163
  8. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab. 2004 Jan; 89(1):200-6.
    View in: PubMed
    Score: 0.158
  9. Metabolic and molecular basis of insulin resistance. J Nucl Cardiol. 2003 May-Jun; 10(3):311-23.
    View in: PubMed
    Score: 0.151
  10. Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E346-52.
    View in: PubMed
    Score: 0.143
  11. miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity. Diabetes. 2018 12; 67(12):2541-2553.
    View in: PubMed
    Score: 0.108
  12. The regulation of muscle protein turnover in diabetes. Int J Biochem Cell Biol. 2013 Oct; 45(10):2239-44.
    View in: PubMed
    Score: 0.076
  13. Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010 Apr; 95(4):1916-23.
    View in: PubMed
    Score: 0.060
  14. Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus. Diabetologia. 2007 Aug; 50(8):1723-31.
    View in: PubMed
    Score: 0.050
  15. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. J Clin Endocrinol Metab. 2005 Feb; 90(2):1100-5.
    View in: PubMed
    Score: 0.042
  16. Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic. Curr Diab Rep. 2004 Jun; 4(3):213-8.
    View in: PubMed
    Score: 0.041
  17. miR-30a targets gene networks that promote browning of human and mouse adipocytes. Am J Physiol Endocrinol Metab. 2020 10 01; 319(4):E667-E677.
    View in: PubMed
    Score: 0.031
  18. Ubc9 Impairs Activation of the Brown Fat Energy Metabolism Program in Human White Adipocytes. Mol Endocrinol. 2015 Sep; 29(9):1320-33.
    View in: PubMed
    Score: 0.022
  19. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects. Am J Physiol Endocrinol Metab. 2002 Jun; 282(6):E1360-8.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.